A Retrospective Study on the Diagnostic Value of Serum miR-206 in Rhabdomyosarcoma
N/A
N/A
Both
Sarcoma
Trial Information
A Retrospective Study on the Diagnostic Value of Serum miR-206 in Rhabdomyosarcoma
OBJECTIVES:
- Determine whether circulating muscle-specific microRNAs, especially serum miR-206, are
potential biomarkers for rhabdomyosarcoma (RMS).
OUTLINE: Archived serum samples are analyzed for miR-206 expression.
PROJECTED ACCRUAL: A total of 15 samples from patients with alveolar rhabdomyosarcoma (RMS),
15 from patients with embryonal RMS, and 10 from patients without RMS will be accrued for
this study.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- Serum specimens of rhabdomyosarcoma (RMS), embryonal RMS, and non-RMS available from
the Soft Tissue Sarcoma committee of Children's Oncology Group
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Type of Study:
Observational
Study Design:
N/A
Outcome Measure:
Serum miR-206 as a biomaker for RMS
Safety Issue:
No
Principal Investigator
Hajime Hosoi
Investigator Role:
Principal Investigator
Investigator Affiliation:
Kyoto Prefectural University of Medicine
Authority:
United States: Federal Government
Study ID:
CDR0000710881
NCT ID:
NCT01433237
Start Date:
September 2011
Completion Date:
Related Keywords:
- Sarcoma
- embryonal childhood rhabdomyosarcoma
- adult rhabdomyosarcoma
- alveolar childhood rhabdomyosarcoma
- adult soft tissue sarcoma
- childhood rhabdomyosarcoma
- Rhabdomyosarcoma
- Sarcoma
Name | Location |
|---|
